GlassScriptPhysician profile
Virendra A Parikh
NPI 1780676874
$3,271.70
in general payments reported to CMS, 2019-2025
26 companies · $1,002 in 2025
The $1,002 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $11.95 · 2021: $37.03 · 2022: $441 · 2023: $298 · 2024: $426 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,701 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,701.13 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $819.21 | 2019-2022 | |
| Smith+Nephew, INC. | $590.86 | 2022-2025 | Collagenase Santyl, Regranex |
| Organogenesis INC. | $517.36 | 2019-2025 | Puraply, Affinity, Apligraf |
| Kerecis Limited | $282.61 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Tactile Systems Technology INC | $189.91 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Urgo Medical North America, LLC | $140.70 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Paratek Pharmaceuticals, INC. | $137.17 | 2021-2022 | |
| Reprise Biomedical, INC. | $109.23 | 2024-2025 | Miro3d |
| Leo Pharma INC. | $62.95 | 2025 | Spevigo |
| Solventum Corporation | $54.69 | 2024 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Acera Surgical, INC. | $43.84 | 2019-2020 | |
| Ossur Americas, INC. | $38.06 | 2025 | |
| Baxter Healthcare | $31.32 | 2025 | Tisseel |
| Medtronic, INC. | $25.00 | 2024 | |
| Olympus America INC. | $24.85 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $24.36 | 2019 | |
| Averitas Pharma INC. | $22.27 | 2023 | Qutenza |
| Ethicon US, LLC | $22.15 | 2019 | |
| Aroa Biosurgery Incorporated | $21.53 | 2024 | |
| Convatec INC. | $21.28 | 2024 | |
| Mimedx Group, INC. | $16.61 | 2025 | |
| Shionogi INC | $16.38 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.94 | 2019 | |
| Cook Medical LLC | $14.85 | 2019 | |
| Hartmann USA, INC. | $14.63 | 2024 | Zetuvit Plus 10x10 P10 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virendra Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.